Capricor Therapeutics - 23 Year Stock Price History | CAPR
- The all-time high Capricor Therapeutics stock closing price was 8000.00 on December 17, 2002.
- The Capricor Therapeutics 52-week high stock price is 23.40, which is 74.9% above the current share price.
- The Capricor Therapeutics 52-week low stock price is 3.52, which is 73.7% below the current share price.
- The average Capricor Therapeutics stock price for the last 52 weeks is 11.40.
Capricor Therapeutics Historical Annual Stock Price Data | ||||||
---|---|---|---|---|---|---|
Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
2025 | 12.3331 | 14.9600 | 15.9500 | 6.3400 | 13.3800 | -3.04% |
2024 | 8.2706 | 5.1200 | 21.9900 | 3.5600 | 13.8000 | 182.21% |
2023 | 4.3936 | 3.8500 | 7.8500 | 2.7100 | 4.8900 | 26.68% |
2022 | 4.3533 | 3.1800 | 6.5500 | 2.8300 | 3.8600 | 31.74% |
2021 | 4.4994 | 3.7400 | 7.9300 | 2.8900 | 2.9300 | -14.58% |
2020 | 3.9987 | 1.2300 | 9.8100 | 0.9400 | 3.4300 | 167.97% |
2019 | 3.6947 | 4.9500 | 6.7990 | 1.0400 | 1.2800 | -68.78% |
2018 | 12.6679 | 15.7000 | 20.9000 | 3.2000 | 4.1000 | -74.05% |
2017 | 19.8844 | 25.5000 | 34.5000 | 6.3400 | 15.8000 | -40.60% |
2016 | 31.8688 | 29.4000 | 47.5000 | 20.1000 | 26.6000 | -13.46% |
2015 | 52.2585 | 37.5000 | 102.5000 | 26.5000 | 30.7360 | -18.04% |
2014 | 59.9506 | 34.0000 | 155.0000 | 34.0000 | 37.5000 | 15.38% |
2013 | 37.0096 | 20.0000 | 92.5000 | 14.5000 | 32.5000 | 33.47% |
2012 | 119.4879 | 272.5000 | 290.0000 | 13.0000 | 24.3500 | -91.06% |
2011 | 317.3097 | 290.0000 | 439.7000 | 240.0000 | 272.5000 | -12.10% |
2010 | 352.5188 | 590.0000 | 629.9500 | 150.0000 | 310.0000 | -48.76% |
2009 | 593.0480 | 400.0000 | 1080.0000 | 165.0500 | 605.0000 | 42.35% |
2008 | 1943.6163 | 2750.0000 | 2750.0000 | 210.0000 | 425.0000 | -84.55% |
2007 | 2259.5750 | 1750.0000 | 3250.0000 | 450.0000 | 2750.0000 | 37.50% |
2006 | 2635.0000 | 1750.0000 | 3750.0000 | 1750.0000 | 2000.0000 | -38.46% |
2005 | 2809.0909 | 2550.0000 | 3250.0000 | 2500.0000 | 3250.0000 | 0.00% |
2004 | 3778.5714 | 3750.0000 | 6250.0000 | 2550.0000 | 3250.0000 | 27.45% |
2003 | 5977.2321 | 7000.0000 | 7500.0000 | 2550.0000 | 2550.0000 | -63.57% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $0.650B | $0.022B |
Capricor Therapeutics, Inc. is a biotechnology company. It is focused on the development of novel therapeutics to prevent and treat heart disease. The Company has two drug candidates in development: Cenderitide and CU-NP. Capricor Therapeutics, Inc., formerly known as Nile Therapeutics, Inc., is based in San Mateo, California. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $232.407B | 27.95 |
Boston Scientific (BSX) | United States | $151.037B | 37.81 |
Stryker (SYK) | United States | $146.527B | 30.64 |
EssilorLuxottica (ESLOY) | France | $129.703B | 0.00 |
Medtronic (MDT) | Ireland | $112.146B | 15.90 |
Lonza Group Ag (LZAGY) | Switzerland | $50.313B | 0.00 |
Haleon (HLN) | United Kingdom | $49.826B | 28.39 |
ResMed (RMD) | United States | $36.979B | 27.77 |
Agilent Technologies (A) | United States | $32.895B | 21.44 |
GE HealthCare Technologies (GEHC) | United States | $32.794B | 15.57 |
Terumo (TRUMY) | Japan | $26.561B | 34.50 |
Koninklijke Philips (PHG) | Netherlands | $22.051B | 15.85 |
Insulet (PODD) | United States | $21.941B | 86.12 |
Zimmer Biomet Holdings (ZBH) | United States | $18.277B | 11.74 |
Baxter (BAX) | United States | $15.529B | 11.59 |
Smith & Nephew SNATS (SNN) | United Kingdom | $13.253B | 0.00 |
Demant (WILYY) | Denmark | $8.854B | 0.00 |
Sunny Optical Technology (SNPTF) | China | $8.430B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $5.971B | 20.78 |
Lantheus Holdings (LNTH) | United States | $5.642B | 14.23 |
Prestige Consumer Healthcare (PBH) | United States | $4.203B | 18.78 |
Perrigo (PRGO) | Ireland | $3.596B | 9.11 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
Haemonetics (HAE) | United States | $3.385B | 15.42 |
ICU Medical (ICUI) | United States | $3.275B | 24.15 |
Envista Holdings (NVST) | United States | $3.174B | 26.38 |
GN Store Nord (GNNDY) | Denmark | $2.180B | 18.06 |
QuidelOrtho (QDEL) | United States | $1.997B | 13.73 |
LeMaitre Vascular (LMAT) | United States | $1.901B | 42.49 |
AtriCure (ATRC) | United States | $1.730B | 0.00 |
Acuren (TIC) | United States | $1.271B | 0.00 |
AdaptHealth (AHCO) | United States | $1.201B | 12.19 |
Neogen (NEOG) | United States | $1.131B | 14.47 |
BioLife Solutions (BLFS) | United States | $1.126B | 0.00 |
Green Thumb Industries (GTBIF) | United States | $1.100B | 24.74 |
Kestra Medical Technologies (KMTS) | United States | $1.063B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.976B | 12.48 |
InMode (INMD) | Israel | $0.895B | 9.02 |
Evolus (EOLS) | United States | $0.647B | 0.00 |
CeriBell (CBLL) | United States | $0.647B | 0.00 |
Owens & Minor (OMI) | United States | $0.619B | 5.13 |
Maravai LifeSciences Holdings (MRVI) | United States | $0.609B | 0.00 |
Curaleaf Holdings (CURLF) | Canada | $0.584B | 0.00 |
Valneva SE (VALN) | France | $0.524B | 0.00 |
Surmodics (SRDX) | United States | $0.420B | 0.00 |
Tilray Brands (TLRY) | Canada | $0.408B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.347B | 12.76 |
SNDL (SNDL) | Canada | $0.347B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.322B | 57.20 |
Canopy Growth (CGC) | Canada | $0.313B | 0.00 |
SEMPERIT AG HLD (SEIGY) | Austria | $0.291B | 0.00 |
Cerus (CERS) | United States | $0.289B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.266B | 22.40 |
Cresco Labs (CRLBF) | United States | $0.265B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.262B | 0.00 |
ZimVie (ZIMV) | United States | $0.261B | 11.87 |
Sanuwave Health (SNWV) | United States | $0.239B | 0.00 |
Omeros (OMER) | United States | $0.221B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.216B | 0.00 |
Biote (BTMD) | United States | $0.210B | 5.89 |
Quanterix (QTRX) | United States | $0.209B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.204B | 0.00 |
Brainsway (BWAY) | Israel | $0.197B | 52.25 |
High Tide (HITI) | Canada | $0.193B | 0.00 |
Verano Holdings (VRNOF) | United States | $0.192B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.182B | 14.86 |
Organigram Global (OGI) | Canada | $0.181B | 0.00 |
Exagen (XGN) | United States | $0.154B | 0.00 |
Vireo Growth (VREOF) | United States | $0.139B | 0.00 |
FitLife Brands (FTLF) | United States | $0.134B | 0.00 |
Jin Medical (ZJYL) | China | $0.120B | 0.00 |
MacroGenics (MGNX) | United States | $0.112B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
Veru (VERU) | United States | $0.091B | 0.00 |
Fonar (FONR) | United States | $0.090B | 11.59 |
Quipt Home Medical (QIPT) | United States | $0.087B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.082B | 0.00 |
Agape ATP (ATPC) | $0.077B | 0.00 | |
InterCure (INCR) | Israel | $0.068B | 0.00 |
Cytosorbents (CTSO) | United States | $0.066B | 0.00 |
Zynex (ZYXI) | United States | $0.066B | 0.00 |
Apyx Medical (APYX) | United States | $0.063B | 0.00 |
ImmuCell (ICCC) | United States | $0.059B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.058B | 0.00 |
Modular Medical (MODD) | United States | $0.046B | 0.00 |
United-Guardian (UG) | United States | $0.038B | 13.14 |
Nephros (NEPH) | United States | $0.036B | 48.00 |
Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
Safety Shot (SHOT) | United States | $0.020B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.019B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.017B | 0.00 |
INLIF (INLF) | $0.016B | 0.00 | |
Flora Growth (FLGC) | United States | $0.014B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
Senestech (SNES) | United States | $0.005B | 0.00 |
GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
Akanda (AKAN) | Canada | $0.002B | 0.00 |
Sharps Technology (STSS) | United States | $0.000B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |